Your browser doesn't support javascript.
loading
Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma.
Cabirta, Alba; Hidalgo-Gómez, Gloria; Marín-Niebla, Ana; Gallur, Laura; Saumell, Silvia; Castellví, Josep; Catalá, Eva; Blanco, Adoración; López-Andreoni, Laura; Montoro, María Julia; Navarrete, Mayda; Palacio-García, Carlos; Tazón-Vega, Bárbara; Bobillo, Sabela; Bosch, Francesc; Ortega, Margarita.
Affiliation
  • Cabirta A; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hidalgo-Gómez G; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Marín-Niebla A; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Gallur L; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Saumell S; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Castellví J; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Catalá E; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Blanco A; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • López-Andreoni L; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Montoro MJ; Department of Pathology, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Navarrete M; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Palacio-García C; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Tazón-Vega B; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Bobillo S; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Bosch F; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Ortega M; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Leuk Lymphoma ; 63(7): 1746-1749, 2022 07.
Article in En | MEDLINE | ID: mdl-35129412
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Diagnostic_studies Limits: Adult / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Diagnostic_studies Limits: Adult / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: